237 related articles for article (PubMed ID: 32675800)
21. Influence of MTHFR C677T gene polymorphism in the development of cardiovascular disease in Egyptian patients with rheumatoid arthritis.
Abd El-Aziz TA; Mohamed RH
Gene; 2017 Apr; 610():127-132. PubMed ID: 28215593
[TBL] [Abstract][Full Text] [Related]
22. Association between the MTHFR C677T gene polymorphism and essential hypertension in South West Cameroon.
Ghogomu SM; Ngolle NE; Mouliom RN; Asa BF
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051013
[TBL] [Abstract][Full Text] [Related]
23. A Potential Strategy for Atherosclerosis Prevention in Modernizing China - Hyperhomocysteinemia, MTHFR C677T Polymorphism and Air Pollution (PM2.5) on Atherogenesis in Chinese Adults.
Kwok CYT; Poon YKP; Chook P; Guo DS; Lin CQ; Yin YH; Celermajer DS; Woo KS
J Nutr Health Aging; 2023; 27(2):134-141. PubMed ID: 36806868
[TBL] [Abstract][Full Text] [Related]
24. 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism and peripheral arterial disease: A meta-analysis.
Liu F; Du J; Nie M; Fu J; Sun J
Vascular; 2021 Dec; 29(6):913-919. PubMed ID: 33357155
[TBL] [Abstract][Full Text] [Related]
25. [Arterial Hypertension and Methylenetetrahydrofolate Reductase C677T Gene Polymorphism].
Pavlova OS; Ogurtsova SE; Liventseva MM; Korobko IY; Mrochek AG
Kardiologiia; 2018 Oct; (10):5-11. PubMed ID: 30359211
[TBL] [Abstract][Full Text] [Related]
26. Croatian population data for the C677T polymorphism in methylenetetrahydrofolate reductase: frequencies in healthy and atherosclerotic study groups.
Zuntar I; Topić E; Vukosavić D; Vuković V; Demarin V; Begonja A; Antoljak N; Simundić AM
Clin Chim Acta; 2003 Sep; 335(1-2):95-100. PubMed ID: 12927690
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between polymorphism C677T of the methylene tetrahydrofolate reductase gene with clinical symptoms of coronary atherosclerosis].
Spiridonova MG; Stepanov VA; Pyzyrev VP; Karpov RS
Genetika; 2000 Sep; 36(9):1269-73. PubMed ID: 11042814
[TBL] [Abstract][Full Text] [Related]
28. [Peroxisome proliferator-activated receptor gamma C-161T polymorphism and carotid artery atherosclerosis in metabolic syndrome].
Yan ZC; Zhu ZM; Shen CY; Zhao ZG; Ni YX; Zhong J; Nie H
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):543-7. PubMed ID: 15144586
[TBL] [Abstract][Full Text] [Related]
29. Methylenetetrahydrofolate reductase C677T variant and hyperhomocysteinemia in subarachnoid hemorrhage patients from India.
Kumar M; Goudihalli S; Mukherjee K; Dhandapani S; Sandhir R
Metab Brain Dis; 2018 Oct; 33(5):1617-1624. PubMed ID: 29926428
[TBL] [Abstract][Full Text] [Related]
30. Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD.
Nakai K; Itoh C; Nakai K; Habano W; Gurwitz D
Am J Cardiovasc Drugs; 2001; 1(5):353-61. PubMed ID: 14728017
[TBL] [Abstract][Full Text] [Related]
31. MTHFR gene C677T and A1298C variants are associated with FMF risk in a Turkish cohort.
Nursal AF; Kaya S; Sezer O; Karakus N; Yigit S
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28543752
[TBL] [Abstract][Full Text] [Related]
32. Polymorphism of the methylenetetrahydrofolate reductase gene C677T and its influence on the antihypertensive and vascular protective effects of short-term lercanidipine treatment.
Xu H; Zheng H; Shen Y; Huang J; Luo M
Gene; 2012 Jun; 500(2):207-10. PubMed ID: 22503897
[TBL] [Abstract][Full Text] [Related]
33. The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease.
Gardemann A; Weidemann H; Philipp M; Katz N; Tillmanns H; Hehrlein FW; Haberbosch W
Eur Heart J; 1999 Apr; 20(8):584-92. PubMed ID: 10337543
[TBL] [Abstract][Full Text] [Related]
34. Association of MTHFR C677T gene polymorphism with metabolic syndrome in a Chinese population: a case-control study.
Wang J; Xu L; Xia H; Li Y; Tang S
J Int Med Res; 2018 Jul; 46(7):2658-2669. PubMed ID: 29658358
[TBL] [Abstract][Full Text] [Related]
35. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
[TBL] [Abstract][Full Text] [Related]
36. Effect of MTHFR Gene Polymorphism Impact on Atherosclerosis via Genome-Wide Methylation.
Lin X; Zhang W; Lu Q; Lei X; Wang T; Han X; Ma A
Med Sci Monit; 2016 Feb; 22():341-5. PubMed ID: 26828698
[TBL] [Abstract][Full Text] [Related]
37. Gender-specific interactions of MTHFR C677T and MTRR A66G polymorphisms with overweight/obesity on serum lipid levels in a Chinese Han population.
Zhi X; Yang B; Fan S; Wang Y; Wei J; Zheng Q; Sun G
Lipids Health Dis; 2016 Oct; 15(1):185. PubMed ID: 27793164
[TBL] [Abstract][Full Text] [Related]
38. The relationship between MTHFR C677T gene polymorphism and essential hypertension in a sample of an Algerian population of Oran city.
Amrani-Midoun A; Kiando SR; Treard C; Jeunemaitre X; Bouatia-Naji N
Int J Cardiol; 2016 Dec; 225():408-411. PubMed ID: 27780089
[TBL] [Abstract][Full Text] [Related]
39. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
40. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
